Literature DB >> 21867389

The efficacy of Ankaferd Blood Stopper for the management of bleeding following total thyroidectomy.

Mehmet Guler1, Gokturk Maralcan, Seval Kul, Ilyas Baskonus, Mehmet Yilmaz.   

Abstract

PURPOSE: Postoperative hematoma remains an uncommon but potentially life-threaten complication of thyroid surgery. The aim of this study is to assess the efficacy of Ankaferd Blood Stopper (ABS) in comparison to hemostasis by conventional technique (HCT) for the controlling of oozing-type bleeding following total thyroidectomy.
METHODS: We randomized 61 patients with benign euthyroid multinodular goiter who underwent total thyroidectomy subject to one of the two different hemostasis techniques. There were 31 patients in the HCT group and 30 patients in the ABS group. The study was designed prospectively to compare ABS and HCT groups in terms of operation time, postoperative drainage, duration of postoperative stay, and complications.
RESULTS: Mean postoperative drainage from the closed suction drains at first 24 hr were 24.6 ± 8.6 ml and 12.0 ± 9.2 ml (p = .001) and mean total postoperative drainage were 38.5 ± 13.2 ml and 20.6 ± 12.2 ml (p = .001) in the HCT and ABS groups, respectively, indicating statistically significant differences.
CONCLUSIONS: On the basis of the results of this trial, the use of ABS seems to be more effective than HCT to control hemorrhage following total thyroidectomy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21867389     DOI: 10.3109/08941939.2011.586092

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  9 in total

1.  Does adrenaline spraying over thyroidectomy area reduce bleeding?

Authors:  Yeliz E Ersoy; Erhan Aysan; Aysenur Meric; Huseyin Kadioglu; Merve B Cengiz; Suleyman Bozkurt; Naim Memmi; Gokhan Cipe; Mahmut Muslumanoglu
Journal:  Int J Clin Exp Med       Date:  2014-01-15

2.  Massive haematuria successfully managed by intravesical Ankaferd in a haemodialysis patient complicated with disseminated intravascular coagulation.

Authors:  Yalcin Solak; Abduzhappar Gaipov; Orhan Ozbek; Mustafa Aziz Hassan; Mehdi Yeksan
Journal:  BMJ Case Rep       Date:  2012-12-23

3.  Hemostatic agent use in thyroid surgery: a meta-analysis.

Authors:  Helmi Khadra; Mohamed Bakeer; Adam Hauch; Tian Hu; Emad Kandil
Journal:  Gland Surg       Date:  2018-08

4.  Evaluation of local hemostatic effect of microporous polysaccharide hemospheres products in thyroid surgery: a prospective randomized controlled study.

Authors:  Enver Kunduz; Erhan Aysan; Ufuk Oğuz İdiz; Yeliz Emine Ersoy; Hüseyin Kazım Bektaşoğlu; Samet Yığman; Hacer Kundakcıoğlu
Journal:  Turk J Surg       Date:  2019-03-01

5.  Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids.

Authors:  Ahmet Koluman; Nejat Akar; Umit Y Malkan; Ibrahim C Haznedaroglu
Journal:  Biomed Res Int       Date:  2016-01-26       Impact factor: 3.411

6.  Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level.

Authors:  Emre Huri; Engin Dogantekin; Murvet Hayran; Umit Yavuz Malkan; Mine Ergun; Aysegul Firat; Yavuz Beyazit; Huseyin Ustun; Murat Kekilli; Mumtaz Dadali; Muzeyyen Astarci; Ibrahim C Haznedaroglu
Journal:  Springerplus       Date:  2016-11-08

Review 7.  Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper.

Authors:  Cem Simsek; Sebnem Selek; Meltem Koca; Ibrahim Celal Haznedaroglu
Journal:  SAGE Open Med       Date:  2017-07-27

8.  Generation of Chimeric "ABS Nanohemostat" Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model.

Authors:  Emre Huri; Yavuz Beyazit; Rashad Mammadov; Sila Toksoz; Ayse B Tekinay; Mustafa O Guler; Huseyin Ustun; Murat Kekilli; Mumtaz Dadali; Tugrul Celik; Müzeyyen Astarci; Ibrahim C Haznedaroglu
Journal:  Int J Biomater       Date:  2013-02-20

Review 9.  Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).

Authors:  Rafiye Ciftciler; Ali Erdinc Ciftciler; Umit Yavuz Malkan; Ibrahim C Haznedaroglu
Journal:  SAGE Open Med       Date:  2020-02-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.